Bellevue Group AG
Reports for
BB Biotech AG
Bellevue Asset Management AG
Filing Date
Global Rank
#781
/ 8,700
▲ 128
Top Industry
Biotechnology
59.4%
Period ended 2 months ago
Filed Aug 14, 2026 · 30d
26 quarters · since Mar 2020
Portfolio Concentration
147 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
6.7%
−0.8 pts
Top 5
29.1%
+2.5 pts
Top 10
43.8%
+0.7 pts
HHI
289
Diversified+2
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.9% | $4,616,199,615 |
| Unclassified | 0.0% | $2,016,279 |
| Technology | 0.0% | $1,191,156 |
| Consumer Cyclical | 0.0% | $382,535 |
| Communication Services | 0.0% | $324,134 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| INSM | INSMED Inc | +1,383,384 | 1,393,418 | $148,566,226 | |
| BBIO | BridgeBio Pharma, Inc. | +1,164,129 | 1,189,506 | $88,594,406 | |
| ORKA | Oruka Therapeutics, Inc. | +1,150,182 | 1,657,190 | $157,714,772 | |
| GILD | Gilead Sciences, Inc. | +988,893 | 2,158,772 | $272,739,254 | |
| PCVX | Vaxcyte, Inc. | +781,238 | 1,971,935 | $114,628,581 | |
| AMGN | Amgen Inc | +556,192 | 851,550 | $308,363,285 | |
| UTHR | UNITED THERAPEUTICS Corp | +186,438 | 188,515 | $102,143,081 | |
| ALKS | Alkermes plc. | +111,373 | 120,243 | $6,300,733 | |
| IRON | Disc Medicine, Inc. | +100,686 | 560,000 | $40,958,400 | |
| TEVA | Teva Pharmaceutical Industries Ltd | +95,817 | 345,899 | $11,719,058 | |
| CVS | CVS HEALTH Corp | +80,003 | 169,366 | $17,520,912 | |
| RPRX | Royalty Pharma plc | +74,015 | 112,311 | $6,297,277 | |
| NAMS | NewAmsterdam Pharma Co N.V. | +59,333 | 86,994 | $2,948,226 | |
| SYK | Stryker Corp | +51,224 | 268,461 | $84,522,261 | |
| PTGX | Protagonist Therapeutics, Inc | +41,235 | 55,682 | $6,825,499 | |
| WAY | Waystar Holding Corp. | +37,453 | 293,592 | $6,027,443 | |
| MDT | Medtronic plc | +36,904 | 994,233 | $77,778,847 | |
| DXCM | Dexcom Inc | +33,723 | 822,489 | $55,394,634 | |
| NBIX | Neurocrine Biosciences Inc | +19,391 | 24,037 | $4,051,195 | |
| TMO | Thermo Fisher Scientific Inc. | +15,404 | 79,816 | $40,016,549 | |
| KMTS | Kestra Medical Technologies, Ltd. | +13,625 | 129,215 | $3,287,229 | |
| ADPT | Adaptive Biotechnologies Corp | +13,258 | 89,439 | $0 | |
| CYTK | Cytokinetics Inc | +10,166 | 19,007 | $1,619,206 | |
| PHR | Phreesia, Inc. | +9,503 | 140,495 | $1,445,693 | |
| LIVN | LivaNova PLC | +9,436 | 195,621 | $16,085,914 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| TNGX | Tango Therapeutics, Inc. | −1,705,818 | 694,182 | $21,700,129 | |
| RLAY | Relay Therapeutics, Inc. | −1,609,272 | 6,185,970 | $115,739,498 | |
| SRRK | Scholar Rock Holding Corp | −1,135,026 | 2,449,547 | $134,725,085 | |
| ANNX | Annexon, Inc. | −1,057,274 | 4,100,016 | $23,411,091 | |
| IONS | Ionis Pharmaceuticals Inc | −846,407 | 972,258 | $77,090,336 | |
| ELVN | Enliven Therapeutics, Inc. | −830,867 | 1,490,000 | $75,617,500 | |
| DMRA | Damora Therapeutics, Inc. | −679,154 | 1,618,846 | $42,106,184 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | −660,000 | 2,620,000 | $98,040,400 | |
| BSX | Boston Scientific Corp | −579,244 | 887,650 | $37,884,902 | |
| RVMD | Revolution Medicines, Inc. | −496,442 | 1,048,014 | $196,272,061 | |
| JBIO | Jade Biosciences, Inc. | −443,506 | 3,057,996 | $67,948,671 | |
| KRYS | Krystal Biotech, Inc. | −404,255 | 77,530 | $28,815,575 | |
| RARE | Ultragenyx Pharmaceutical Inc. | −397,225 | 1,982,775 | $66,204,857 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | −233,451 | 1,092 | $328,724 | |
| ABT | Abbott Laboratories | −204,520 | 947,115 | $85,941,215 | |
| GEHC | GE HealthCare Technologies Inc. | −164,143 | 252,744 | $16,178,143 | |
| REGN | Regeneron Pharmaceuticals, Inc. | −121,383 | 157,291 | $98,077,230 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | −103,274 | 578,634 | $287,424,866 | |
| GMED | Globus Medical Inc | −101,153 | 146,108 | $11,543,993 | |
| EW | Edwards Lifesciences Corp | −100,217 | 739,234 | $66,871,107 | |
| MRK | Merck & Co., Inc. | −93,530 | 113,061 | $14,528,338 | |
| COO | Cooper Companies, Inc. | −75,049 | 197,135 | $14,136,550 | |
| PFE | Pfizer Inc | −69,204 | 38,431 | $925,418 | |
| TXG | 10x Genomics, Inc. | −68,022 | 261,470 | $10,024,759 | |
| GLUE | Monte Rosa Therapeutics, Inc. | −60,000 | 1,190,000 | $28,798,000 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
17 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AVLN | Avalyn Pharma Inc. | 1,350,000 | $44,442,000 | |
| CGON | CG Oncology, Inc. | 493,596 | $35,069,995 | |
| SPTX | Seaport Therapeutics, Inc. | 1,100,000 | $23,892,000 | |
| PVLA | Palvella Therapeutics, Inc. | 155,000 | $23,687,100 | |
| SYRE | Spyre Therapeutics, Inc. | 229,931 | $20,413,274 | |
| COAG | Hemab Therapeutics Holdings, Inc. | 550,000 | $20,201,500 | |
| PBLS | Parabilis Medicines, Inc. | 500,000 | $13,685,000 | |
| AURA | Aura Biosciences, Inc. | 1,166,667 | $8,283,335 | |
| MOH | Molina Healthcare, Inc. | 27,761 | $6,348,940 | |
| GMRS | GMR Solutions Inc. | 333,333 | $5,153,328 | |
| ALMR | Alamar Biosciences, Inc. | 55,738 | $1,509,942 | |
| MOBI | Mobia Medical, Inc. | 100,000 | $1,340,000 | |
| MANE | Veradermics, Inc | 3,468 | $426,355 | |
| DFTX | Definium Therapeutics, Inc. | 8,391 | $394,712 | |
| VTRS | Viatris Inc | 15,778 | $250,554 | |
| COGT | Cogent Biosciences, Inc. | 4,870 | $188,469 | |
| WAT | Waters Corp /De/ | 179 | $67,132 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | 1,528,518 | $48,148,317 | |
| INSP | Inspire Medical Systems, Inc. | 99,735 | $5,144,331 | |
| PEN | Penumbra Inc | 12,267 | $4,028,114 | |
| RNA | Atrium Therapeutics, Inc. | 263,096 | $3,517,593 | |
| EQNR | Equinor ASA | 17,573 | $741,580 | |
| XOM | ExxonMobil Holdings Corp | 4,370 | $741,414 | |
| BP | Bp PLC | 15,644 | $735,268 | |
| SHEL | Shell plc | 7,844 | $729,492 | |
| CSCO | Cisco Systems, Inc. | 8,000 | $620,720 | |
| BABA | Alibaba Group Holding Ltd | 4,700 | $589,662 | |
| PG | PROCTER & GAMBLE Co | 3,900 | $563,316 | |
| MA | Mastercard Inc | 1,100 | $549,626 | |
| AFK | VanEck Africa Index ETF | 5,750 | $527,677 | |
| BLK | BlackRock, Inc. | 450 | $432,769 | |
| V | Visa Inc. | 1,400 | $423,136 | |
| JD | JD.com, Inc. | 11,000 | $325,270 | |
| ACN | Accenture plc | 1,500 | $297,435 | |
| ADBE | Adobe Inc. | 1,200 | $291,696 | |
| OLMA | Olema Pharmaceuticals, Inc. | 16,443 | $245,165 | |
| ASND | Ascendis Pharma A/S | 536 | $122,599 | |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 6,982 | $62,488 | |
| WVE | Wave Life Sciences, Inc. | 5,261 | $38,142 | |
| QGEN | Qiagen N.V. | 243 | $9,729 | |
| — | 8,753 | $0 | ||
| CNTA | Centessa Pharmaceuticals plc | 9,030 | $0 | |
| No positions match the current search. | ||||
147 tracked positions ·
$4,620,113,719 total
· filing declares
164 positions · $4,752,644,375
· as of Jun 30, 2026
Showing 1–50
of 147 positions by value
· page 1 of 3
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| AMGN |
Amgen Inc
Healthcare
|
Added | 851,550 | $308,363,285 | 6.67% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Reduced | 578,634 | $287,424,866 | 6.22% | |
| ARGX |
Argenx SE
Healthcare
|
Reduced | 301,000 | $279,258,770 | 6.04% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
Added | 2,158,772 | $272,739,254 | 5.90% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 1,048,014 | $196,272,061 | 4.25% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Added | 1,657,190 | $157,714,772 | 3.41% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 1,393,418 | $148,566,226 | 3.22% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Reduced | 2,449,547 | $134,725,085 | 2.92% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Added | 6,731,909 | $123,665,167 | 2.68% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Reduced | 6,185,970 | $115,739,498 | 2.51% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 1,971,935 | $114,628,581 | 2.48% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Added | 188,515 | $102,143,081 | 2.21% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 254,809 | $101,332,443 | 2.19% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Reduced | 157,291 | $98,077,230 | 2.12% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Reduced | 2,620,000 | $98,040,400 | 2.12% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 1,189,506 | $88,594,406 | 1.92% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Reduced | 2,788,245 | $88,526,778 | 1.92% | |
| ABT |
Abbott Laboratories
Healthcare
|
Reduced | 947,115 | $85,941,215 | 1.86% | |
| SYK |
Stryker Corp
Healthcare
|
Added | 268,461 | $84,522,261 | 1.83% | |
| MDT |
Medtronic plc
Healthcare
|
Added | 994,233 | $77,778,847 | 1.68% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Reduced | 972,258 | $77,090,336 | 1.67% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Reduced | 1,490,000 | $75,617,500 | 1.64% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Added | 1,710,808 | $73,410,770 | 1.59% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Reduced | 3,057,996 | $67,948,671 | 1.47% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Reduced | 739,234 | $66,871,107 | 1.45% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Reduced | 1,982,775 | $66,204,857 | 1.43% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 149,127 | $61,981,655 | 1.34% | |
| DXCM |
Dexcom Inc
Healthcare
|
Added | 822,489 | $55,394,634 | 1.20% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Held | 1,200,000 | $44,652,000 | 0.97% | |
| AVLN |
Avalyn Pharma Inc.
Healthcare
|
NEW | 1,350,000 | $44,442,000 | 0.96% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
Reduced | 1,618,846 | $42,106,184 | 0.91% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 560,000 | $40,958,400 | 0.89% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Added | 79,816 | $40,016,549 | 0.87% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Reduced | 887,650 | $37,884,902 | 0.82% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 29,882 | $35,841,370 | 0.78% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
NEW | 493,596 | $35,069,995 | 0.76% | |
| IDXX |
Idexx Laboratories Inc /De
Healthcare
|
Reduced | 61,780 | $32,523,463 | 0.70% | |
| RMD |
Resmed Inc
Healthcare
|
Reduced | 148,195 | $28,880,241 | 0.63% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Reduced | 77,530 | $28,815,575 | 0.62% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Reduced | 1,190,000 | $28,798,000 | 0.62% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Reduced | 143,844 | $27,399,405 | 0.59% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Reduced | 103,280 | $26,230,021 | 0.57% | |
| SPTX |
Seaport Therapeutics, Inc.
Healthcare
|
NEW | 1,100,000 | $23,892,000 | 0.52% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
NEW | 155,000 | $23,687,100 | 0.51% | |
| ALGN |
Align Technology Inc
Healthcare
|
Held | 139,680 | $23,558,428 | 0.51% | |
| ANNX |
Annexon, Inc.
Healthcare
|
Reduced | 4,100,016 | $23,411,091 | 0.51% | |
| HUM |
Humana Inc
Healthcare
|
Reduced | 58,398 | $23,196,853 | 0.50% | |
| ELV |
Elevance Health, Inc.
Healthcare
|
Added | 56,449 | $21,830,521 | 0.47% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Reduced | 694,182 | $21,700,129 | 0.47% | |
| STE |
STERIS plc
Healthcare
|
Reduced | 99,877 | $21,031,099 | 0.46% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.